Harbor Capital Advisors, Inc. Agios Pharmaceuticals, Inc. Transaction History
Harbor Capital Advisors, Inc.
- $1.31 Billion
- Q2 2024
A detailed history of Harbor Capital Advisors, Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 32,770 shares of AGIO stock, worth $1.33 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
32,770
Previous 19,276
70.0%
Holding current value
$1.33 Million
Previous $564,000
150.53%
% of portfolio
0.11%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
227Shares Held
56.3MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$229 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.5MShares$223 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$197 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$157 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$113 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.22B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...